Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 6
1976 6
1977 4
1978 7
1979 9
1980 8
1981 26
1982 41
1983 134
1984 150
1985 186
1986 175
1987 195
1988 181
1989 228
1990 219
1991 193
1992 251
1993 271
1994 243
1995 273
1996 258
1997 304
1998 315
1999 301
2000 284
2001 368
2002 368
2003 319
2004 350
2005 353
2006 345
2007 396
2008 387
2009 363
2010 401
2011 396
2012 362
2013 414
2014 384
2015 409
2016 402
2017 399
2018 364
2019 335
2020 183
Text availability
Article attribute
Article type
Publication date

Search Results

10,978 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis B vaccine and the need for a booster dose after primary vaccination.
Pileggi C, Papadopoli R, Bianco A, Pavia M. Pileggi C, et al. Vaccine. 2017 Nov 1;35(46):6302-6307. doi: 10.1016/j.vaccine.2017.09.076. Epub 2017 Oct 5. Vaccine. 2017. PMID: 28988867
OBJECTIVES: Protective antibodies levels, induced by Hepatitis B virus (HBV) vaccine, persist for long-term after primary immunization, but there is evidence that, as the time since vaccination increases, there is a reduced ability to maintain immune memory. …
OBJECTIVES: Protective antibodies levels, induced by Hepatitis B virus (HBV) vaccine, persist for long-term after prima …
Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States.
Splawn LM, Bailey CA, Medina JP, Cho JC. Splawn LM, et al. Drugs Today (Barc). 2018 Jul;54(7):399-405. doi: 10.1358/dot.2018.54.7.2833984. Drugs Today (Barc). 2018. PMID: 30090877 Review.
The current standard of hepatitis B vaccination in the United States is the Engerix-B vaccine, which consists of a three-dose regimen over a 6-month time period. A new hepatitis B vaccine, Heplisav-B, has been approved for a …
The current standard of hepatitis B vaccination in the United States is the Engerix-B vaccine, which consists of …
Influences of obesity on the immunogenicity of Hepatitis B vaccine.
Liu F, Guo Z, Dong C. Liu F, et al. Hum Vaccin Immunother. 2017 May 4;13(5):1014-1017. doi: 10.1080/21645515.2016.1274475. Epub 2017 Jan 6. Hum Vaccin Immunother. 2017. PMID: 28059607 Free PMC article. Review.
OBJECTIVE: Hepatitis B vaccine is regarded as the most effective method for the prevention of hepatitis B virus (HBV) infection. ...Therefore, more studies should be performed to analyze the influences of obesity on the immunogenicity of hepa
OBJECTIVE: Hepatitis B vaccine is regarded as the most effective method for the prevention of hepatitis B
[Hepatitis B vaccine].
Sociedade Brasileira de Pediatria. Sociedade Brasileira de Pediatria. Rev Assoc Med Bras (1992). 2006 Sep-Oct;52(5):288-9. doi: 10.1590/s0104-42302006000500009. Rev Assoc Med Bras (1992). 2006. PMID: 17269193 Review. Portuguese. No abstract available.
Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.
Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Vitaliti G, et al. World J Gastroenterol. 2013 Feb 14;19(6):838-45. doi: 10.3748/wjg.v19.i6.838. World J Gastroenterol. 2013. PMID: 23430309 Free PMC article. Review.
Some studies showed that in celiac patients the immunological response to vaccination is similar to that one found in general population except for vaccine against hepatitis B virus (HBV). ...Moreover, it has been demonstrated a possible genetic predispositio …
Some studies showed that in celiac patients the immunological response to vaccination is similar to that one found in general population exc …
Hepatitis B vaccine response in obesity: A meta-analysis.
Fan W, Chen XF, Shen C, Guo ZR, Dong C. Fan W, et al. Vaccine. 2016 Sep 14;34(40):4835-41. doi: 10.1016/j.vaccine.2016.08.027. Epub 2016 Aug 18. Vaccine. 2016. PMID: 27546877
BACKGROUND: Hepatitis B vaccination is critical in preventing hepatitis B virus (HBV) infection and transmission. However, the impact of obesity on immune response to hepatitis B vaccine remains unclear. ...CONCLUSIONS: The present …
BACKGROUND: Hepatitis B vaccination is critical in preventing hepatitis B virus (HBV) infection and transmission …
Should hepatitis B vaccine be used for infants?
Mansoor OD, Salama P. Mansoor OD, et al. Expert Rev Vaccines. 2007 Feb;6(1):29-33. doi: 10.1586/14760584.6.1.29. Expert Rev Vaccines. 2007. PMID: 17280476 Review.
But the evidence to date does not support any association of hepatitis B vaccine with serious adverse consequences. Protecting infants through immunization is the most effective control strategy. ...The possible future cost from a single infant infection argu …
But the evidence to date does not support any association of hepatitis B vaccine with serious adverse consequences. Pro …
Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M. Verma R, et al. Hum Vaccin. 2011 Dec;7(12):1387-8. doi: 10.4161/hv.7.12.17878. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22134433
World Health Organization (WHO) recommends that Hepatitis B vaccine should be given to all infants. Several cost-effectiveness analyses of inclusion of Hepatitis B vaccine in India's NIP have been performed. ...The current immunization sc …
World Health Organization (WHO) recommends that Hepatitis B vaccine should be given to all infants. Several cost-effect …
[Hepatitis B vaccine].
[No authors listed] [No authors listed] Rev Saude Publica. 2006 Dec;40(6):1137-40. Rev Saude Publica. 2006. PMID: 17173175 Free article. Portuguese. No abstract available.
[Use of hepatitis B AS04C adjuvanted vaccine in HIV patients].
Fernández-Prada M, Rodríguez-Fonseca OD, Brandy-García AM, Alonso-Penanes P, Huerta-González I, Fernández-Noval F. Fernández-Prada M, et al. Rev Esp Quimioter. 2018 Apr;31(2):105-109. Epub 2018 Mar 19. Rev Esp Quimioter. 2018. PMID: 29564866 Free PMC article. Spanish.
The objective is to identify the response rate following the use of AS04C-adjuvanted hepatitis B vaccine in HIV patients as well as the possible associated adverse reactions. ...CONCLUSIONS: The administration of AS04C-adjuvanted hepatitis B
The objective is to identify the response rate following the use of AS04C-adjuvanted hepatitis B vaccine in HIV patient …
10,978 results
Jump to page
Feedback